Skip to the answer

Semaglutide Uses, Dosage, Side Effects and Interactions

Brand names
Rybelsus

Rybelsus came a year after Ozempic (September 2019) as a tablet. No generic is listed as tablets.

First generic of Rybelsus: our estimate, 2032 to 2033

Ozempic

Ozempic was the first semaglutide product the FDA approved, in December 2017. No generic is listed as injections and tablets.

First generic of Ozempic: our estimate, 2031 to 2032

Wegovy

Wegovy came 3 years after Ozempic (June 2021). No generic is listed as injections and tablets.

Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and lower heart and kidney risks in adults with type 2 diabetes, and to reduce excess body weight, heart risk and, with Wegovy injection, certain liver disease.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About SemaglutideType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Semaglutide in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Semaglutide (Ozempic, Wegovy, Rybelsus) mimics the gut hormone GLP-1 to boost insulin release, slow the stomach and curb appetite, and since reaching the U.S. market around 2017 it has become widely prescribed for type 2 diabetes (with heart and kidney benefits), weight management, heart risk reduction and, as Wegovy injection, MASH (fatty liver with scarring). Most people tolerate it, though nausea, diarrhea or constipation are common early and usually ease. Its boxed warning covers thyroid C-cell tumors seen in rodents (unknown in people), so it is off-limits with a personal or family history of medullary thyroid cancer or MEN 2 (an inherited gland condition).

Key Takeaways From the HelloPharmacist Team

  • Inject Ozempic or Wegovy once a week on the same day; take tablets each morning on an empty stomach, then wait 30 minutes.
  • Stop it and call your doctor for severe stomach pain reaching your back; face or throat swelling needs emergency care.
  • Sip fluids through any bout of vomiting or diarrhea, because dehydration on semaglutide can injure the kidneys.
  • Never combine Ozempic, Wegovy or Rybelsus with each other or another GLP-1 medicine, and never share a pen.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Semaglutide.

Semaglutide caused thyroid tumors in rodents, and it is not known whether it does so in people. You should not use it if you or a close relative has had medullary thyroid carcinoma (a type of thyroid cancer) or if you have MEN 2, a genetic condition. Tell your doctor right away about a lump in your neck, trouble swallowing, trouble breathing or hoarseness that does not go away. Routine blood tests or thyroid ultrasounds are of uncertain value for catching these tumors early.

Read the full warning on DailyMed →

Semaglutide by the Numbers

Strengths
16
across 2 forms
Makers and packagers
2
Earliest FDA record
2017
Rank by Medicaid prescriptions
#31 of 1,682 drugs
More prescriptions than 98% of the 1,682 drugs we measure
5.81 million prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Semaglutide

What It’s Used For

Semaglutide products are approved for different uses depending on the brand and form.

  • Ozempic injection: improves blood sugar control in adults with type 2 diabetes.
  • Ozempic injection: lowers risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
  • Ozempic injection: lowers risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
  • Rybelsus and Ozempic tablets: improve blood sugar control in adults with type 2 diabetes and lower cardiovascular event risk in those at high risk.
  • Wegovy injection and tablets: lower cardiovascular event risk in adults with established cardiovascular disease and obesity or overweight.
  • Wegovy injection and tablets: reduce excess body weight and maintain weight loss in adults with obesity, or overweight plus a weight-related condition.
  • Wegovy injection: also for weight reduction in children 12 and older with obesity.
  • Wegovy injection: treats noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval).

How It Works

Semaglutide is a GLP-1 analogue that binds to and activates GLP-1 receptors. GLP-1 helps regulate appetite and calorie intake, and its receptors are found in brain areas that control appetite. Semaglutide also boosts insulin release and lowers glucagon when blood sugar is high. How it lowers cardiovascular risk and treats MASH is not fully understood.

Drug Class

Drug Class

  • GLP-1 Receptor Agonist
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • GLP-1 Receptor Agonist

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Glucagon-like Peptide-1 (GLP-1) Agonists

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Semaglutide in the FDA’s index.

From our Patient Information GuideSemaglutide is a GLP-1 analogue that binds to and activates GLP-1 receptors. GLP-1 helps regulate appetite and calorie intake, and its receptors are found in brain areas that control appetite. Read How Semaglutide Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Glucagon-Like Peptide 1

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Glucagon-like peptide-1 (GLP-1) analogues

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Semaglutide is taken in different ways depending on the product. Doses start low and rise slowly to reduce stomach side effects.

  • Ozempic and Wegovy injections: once weekly under the skin, with or without food, same day each week.
  • Wegovy tablets: once daily in the morning on an empty stomach with plain water, then wait 30 minutes before food, drinks or other pills.
  • Ozempic missed dose: take it within 5 days; after that, skip it and resume your regular day.

Follow your prescriber and the product label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Wegovy Injection

Weight loss and heart risk reduction
Adults and children 12 years and older · Weeks 1 through 4 Starting dose 0.25 mg once a week
  • 0.25 mg subcutaneously once weekly
Dosage escalation, weeks 5 through 8 (all approved indications) Dose 0.5 mg once weekly
  • 0.5 mg subcutaneously once weekly

Good to know

If a dose is not tolerated, consider delaying escalation for 4 weeks

Adults and children 12 years and older · Weeks 9 through 12 Dose 1 mg once weekly
  • 1 mg subcutaneously once weekly
Dosage escalation, weeks 13 through 16 (all approved indications) Dose 1.7 mg once weekly
  • 1.7 mg subcutaneously once weekly
Adults with heart disease and obesity or overweight · Week 17 onward Usual dose 2.4 mg once a week
  • 2.4 mg (recommended) or 1.7 mg once weekly
Adults with obesity or overweight · Week 17 onward Usual dose 2.4 mg once a week Highest dose 7.2 mg once a week

Step by step

  1. 1.7 mg or 2.4 mg (recommended) subcutaneously once weekly
  2. May be increased after at least 4 weeks on 2.4 mg if more weight reduction is needed
Children 12 years and older with obesity · Week 17 onward Usual dose 2.4 mg once a week
  • 2.4 mg (recommended) or 1.7 mg once weekly
Fatty liver disease with scarring (MASH)
For adults · Maintenance dosage
Usual dose 2.4 mg once a week
  • 2.4 mg injected subcutaneously once weekly
  • If not tolerated, may be decreased to 1.7 mg once weekly, with reescalation to 2.4 mg considered

See the Full Dosing Instructions on DailyMed →

Ozempic

Type 2 diabetes
Adults · Starting dose Starting dose 0.25 mg once a week
  • 0.25 mg injected subcutaneously once weekly for 4 weeks, then 0.5 mg once weekly
Adults · Maintenance dose Highest dose 2 mg once a week
  • 0.5 mg, 1 mg, or 2 mg subcutaneously once weekly based on glycemic control
  • Increase to 1 mg after at least 4 weeks on 0.5 mg, to 2 mg after at least 4 weeks on 1 mg

What a maintenance dose is: The regular ongoing dose taken to keep a steady, effective amount of medicine in the body over time.

Adults with chronic kidney disease · Maintenance dose Usual dose 1 mg once a week
  • 1 mg once weekly after at least 4 weeks on the 0.5 mg dosage

See the Full Dosing Instructions on DailyMed →

Rybelsus and Ozempic

Rybelsus tablets, days 1 to 30 starting dosage
For adults taking Rybelsus · Days 1 to 30
Starting dose 3 mg once a day
  • 3 mg orally once daily for 30 days (not effective for glycemic control)
Rybelsus tablets, days 31 to 60
For adults taking Rybelsus · Days 31 to 60
Usual dose 7 mg once a day
Rybelsus tablets, day 61 or thereafter
For adults taking Rybelsus · Day 61 onward
Usual dose 7 mg once a day Highest dose 14 mg once a day

Step by step

  1. 7 mg orally once daily if no additional glycemic control is needed
  2. 14 mg once daily if additional control is needed
Ozempic tablets, days 1 to 30 starting dosage
For adults taking Ozempic tablets · Days 1 to 30
Starting dose 1.5 mg once a day
  • 1.5 mg orally once daily for 30 days (not effective for glycemic control)
Ozempic tablets, days 31 to 60
For adults taking Ozempic tablets · Days 31 to 60
Usual dose 4 mg once a day
Ozempic tablets, day 61 or thereafter
For adults taking Ozempic tablets · Day 61 onward
Usual dose 4 mg once a day Highest dose 9 mg once a day

Step by step

  1. 4 mg orally once daily if no additional glycemic control is needed
  2. 9 mg once daily if additional control is needed

See the Full Dosing Instructions on DailyMed →

Wegovy Tablets

Weight loss and heart risk reduction
Adults · Days 1 through 30 Starting dose 1.5 mg once a day
Adults · Days 31 through 60 Usual dose 4 mg once a day
Adults · Days 61 through 90 Usual dose 9 mg once a day
Adults · Day 91 onward Usual dose 25 mg once a day

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects involve the stomach and are often worst when starting or raising the dose.

Common side effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Stomach pain
  • Headache
  • Tiredness
  • Indigestion or burping
  • Indigestion, bloating and burping
  • Dizziness and hair loss
  • Skin tingling or sensitivity (dysesthesia)

When to get medical help

  • Persistent or severe stomach pain, sometimes spreading to the back, with or without vomiting (possible pancreatitis). Stop the medicine and call your doctor.
  • A lump in the neck, trouble swallowing, trouble breathing or lasting hoarseness (possible thyroid tumor).
  • Swelling of the face or throat, or trouble breathing (serious allergic reaction).
  • Severe or ongoing vomiting or diarrhea leading to dehydration, which can harm the kidneys.
  • Signs of gallbladder problems, such as gallstones or inflamed gallbladder.
  • Signs of low blood sugar, especially if you also use insulin or a sulfonylurea.
  • Vision changes if you have diabetic retinopathy (eye damage from diabetes).

Warnings and Precautions

  • Thyroid tumors (boxed warning): seen in rodents; human risk unknown. Not for people with a history of MTC or MEN 2.
  • Pancreatitis: stop and call your doctor if you have severe, persistent stomach pain.
  • Gallbladder disease: gallstones and gallbladder inflammation have been reported.
  • Kidney injury: can follow dehydration from vomiting or diarrhea.
  • Low blood sugar: higher risk with insulin or sulfonylureas.
  • Diabetic retinopathy: more complications were seen in a trial; people with this history should be monitored.
  • Anesthesia: slowed stomach emptying may lead to aspiration; tell providers before procedures.
  • Pen sharing: never share an Ozempic pen.

Interactions

Semaglutide can affect how other medicines work or add to their effects.

  • Insulin or sulfonylureas: raises low blood sugar risk, so doses may need lowering.
  • Other GLP-1 medicines or semaglutide products: not recommended together.
  • Oral medicines: slowed stomach emptying may change absorption; use caution.
  • Wegovy tablets: wait 30 minutes before taking other oral medicines.

Interactions Listed in the FDA-Approved Label

From the Semaglutide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Insulin secretagogues (e.g., sulfonylureas) or insulin
    What happensUsing Ozempic with these may increase the risk of hypoglycemia, including severe hypoglycemia.
    What to doWhen starting Ozempic, consider reducing the dose of the insulin secretagogue (such as sulfonylureas) or insulin.
  • Oral medications
    What happensOzempic delays gastric emptying and may affect absorption of oral medications taken at the same time; trials showed no clinically relevant effect on absorption.
    What to doUse caution when oral medications are taken with Ozempic.
Read the label’s full interactions text

7 DRUG INTERACTIONS Oral Medications: OZEMPIC delays gastric emptying. May impact absorption of concomitantly administered oral medications. Use with caution. 7.1 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin OZEMPIC stimulates insulin release in the presence of elevated blood glucose concentrations. Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia. When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia. 7.2 Oral Medications OZEMPIC causes a delay of gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications. In clinical pharmacology trials, semaglutide did not affect the absorption of orally administered medications to any clinically relevant degree. Nonetheless, caution should be exercised when oral medications are concomitantly administered with OZEMPIC.

7.1 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin OZEMPIC stimulates insulin release in the presence of elevated blood glucose concentrations. Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia. When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia.

7.2 Oral Medications OZEMPIC causes a delay of gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use with a personal or family history of MTC or MEN 2.
  • Do not use after a serious allergic reaction to semaglutide or its ingredients.
  • Tell your doctor about pancreatitis, diabetic retinopathy, severe gastroparesis or gallbladder problems.
  • Pregnancy: Wegovy may harm a baby; stop when pregnancy is recognized and at least 2 months before planning pregnancy.
  • Breastfeeding is not recommended with Wegovy tablets.
  • Wegovy injection is approved for children 12 and older with obesity; Wegovy tablets and the 7.2 mg injection have not been established in children.
  • Ozempic is not for type 1 diabetes.

Overdose

Overdoses of GLP-1 medicines have caused severe nausea, severe vomiting and severe low blood sugar. Treatment is supportive, based on symptoms. Call Poison Help at 1-800-222-1222. Because semaglutide has a long half-life of about a week, you may need extended observation and treatment.

Half-Life and How Your Body Processes It

Injected semaglutide is about 89% absorbed and peaks in 1 to 3 days. Wegovy tablets use an absorption helper (SNAC), are about 1% to 2% absorbed, and peak in about 1 hour. Semaglutide is heavily bound to albumin and has a half-life of about 1 week, so it stays in the body for 5 to 7 weeks after the last dose. It is broken down by the body and cleared through urine and feces.

Storage

• Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze WEGOVY and do not use if it has been frozen. Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Semaglutide

From the licensed clinical database we use, rolled up per supplement, most serious first.

252 supplements and herbal products have documented interactions with Semaglutide in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 2Major
  • 210Moderate
  • 40Minor

See the other 244

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Nutrients Semaglutide May Deplete

Nutrients Semaglutide has been linked with lower levels of, from the licensed clinical database we use.

Semaglutide has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.

Semaglutide: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Semaglutide — the kind of thing our pharmacy team would talk through with you at the counter.

What happens if I miss a dose of Ozempic?

Take it as soon as you can within 5 days of the missed dose. If more than 5 days have passed, skip it and take your next dose on your usual day. Then go back to your regular weekly schedule.

How should I take Wegovy tablets?

Take one tablet in the morning on an empty stomach with a small amount of plain water, up to 4 ounces. Swallow it whole. Then wait at least 30 minutes before eating, drinking or taking other pills.

What side effects should I expect with semaglutide?

Stomach symptoms are most common, including nausea, diarrhea, vomiting and constipation. Headache, tiredness and dizziness can also occur. Doses are raised gradually to help reduce these effects.

When should I call my doctor about semaglutide?

Call right away for severe stomach pain that does not go away, swelling of the face or throat, trouble breathing, or a neck lump or lasting hoarseness. Also call for vomiting or diarrhea that leaves you dehydrated, or signs of low blood sugar.

Can I take semaglutide with insulin or other diabetes medicines?

Yes, but insulin and sulfonylureas can raise the risk of low blood sugar, so your doctor may lower those doses. Never mix Ozempic and insulin in the same injection. Do not combine semaglutide with other GLP-1 medicines.

Is semaglutide safe during pregnancy?

Wegovy may harm a baby, so you should stop it when pregnancy is recognized. Stop it at least 2 months before planning a pregnancy because it stays in your body for weeks. Talk to your prescriber about your options.

Is semaglutide available over the counter?

No. Semaglutide is a prescription medicine: every semaglutide product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was semaglutide first available?

The earliest FDA record we hold for semaglutide is from 2017: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when semaglutide was first used.

Who makes semaglutide?

2 companies currently list semaglutide products in the FDA's NDC Directory, including Novo Nordisk Pharmaceutical Industries, LP, A-S Medication Solutions. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of semaglutide?

Semaglutide is the generic name. Its brand names are Rybelsus, Ozempic and Wegovy.

What is the generic name of Rybelsus?

The generic name of Rybelsus is semaglutide. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is semaglutide?

Semaglutide belongs to the drug class GLP-1 Receptor Agonist, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Glucagon-like Peptide-1 (GLP-1) Agonist.

What strengths does semaglutide come in?

Semaglutide is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (under the skin): 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL and 7.2 mg/0.75 mL. Injection (under the skin), amount in each mL: 0.68 mg/mL, 1.34 mg/mL and 2.68 mg/mL. Tablet (by mouth): 1.5 mg, 3 mg, 4 mg, 7 mg, 9 mg, 14 mg and 25 mg. A listing does not mean every pharmacy stocks every strength.

How much does semaglutide cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $332.00 to $653.33 per mL of the injection of brand-name Wegovy and Ozempic across 9 strengths and $33.16 to $43.47 per tablet of brand-name Ozempic, Rybelsus and Wegovy across 7 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a semaglutide shortage?

Semaglutide is not on the FDA's drug shortage list as of Nov 21, 2026, but a company has told the FDA it is discontinuing one version of it. See which products the notice covers

Where can I read the semaglutide prescribing information (package insert)?

The full FDA-approved prescribing information for semaglutide, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Novo Nordisk's, revised Jun 18, 2026, and links to it on DailyMed.

Can you crush semaglutide?

Some forms of semaglutide are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: Rybelsus (tablet); semaglutide (tablet). They are listed for a reason such as irritation, a bad taste or a special formulation. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is semaglutide gluten free?

No semaglutide label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 23 semaglutide products from 2 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's semaglutide by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See semaglutide inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Semaglutide

Skip the scrolling. Ask in your own words and get an answer from Semaglutide’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Semaglutide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Semaglutide on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Semaglutide Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Semaglutide Forms and Strengths (How It Comes)

Semaglutide comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Semaglutide inactive ingredients by manufacturer.

Injection

Under the skin
Brands Ozempic (the first brand, 2017) Wegovy (2021)
How this form is used
What it may be used for
  • Ozempic injection is used for blood sugar control in adults with type 2 diabetes.
  • Ozempic injection lowers major cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease, and kidney risks in those with chronic kidney disease.
  • Wegovy injection is used for weight reduction in adults and in children 12 and older with obesity.
  • Wegovy injection is also used for cardiovascular risk reduction and for MASH with moderate to advanced liver fibrosis in adults.
Important instructions
  • Ozempic is injected under the skin once a week, with or without food.
  • Wegovy injection is given under the skin once a week, on the same day each week.
  • Ozempic: if a dose is missed, take it within 5 days; otherwise skip it and resume the usual day.
  • Rotate injection sites, and do not use if the solution is cloudy, colored or has particles.
Available strengths 10 strengths
Show 4 more strengths Show fewer strengths
14 FDA-listed product records ⓘ

Tablet

By mouth
Brands Rybelsus (2019) Ozempic (the first brand, 2017) Wegovy (2021)
How this form is used
What it may be used for
  • Rybelsus and Ozempic tablets are used for blood sugar control in adults with type 2 diabetes.
  • Rybelsus and Ozempic tablets lower major cardiovascular event risk in adults with type 2 diabetes at high risk for these events.
  • Wegovy tablets are used for weight reduction and cardiovascular risk reduction in adults.
Important instructions
  • Wegovy tablets are taken once daily on an empty stomach in the morning with up to 4 ounces of plain water.
  • Swallow Wegovy tablets whole; do not split, crush, chew or dissolve them.
  • Wait at least 30 minutes after a Wegovy tablet before eating, drinking or taking other oral medicines.
Available strengths 7 strengths
Show 1 more strength Show fewer strengths
10 FDA-listed product records ⓘ

Semaglutide on the U.S. Market: Products, Makers and Brands

How Semaglutide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

2 companies list 24 Semaglutide product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 2017. Brand names in the directory today include Rybelsus, Ozempic and Wegovy; the rest are generics.

2
Dose forms ⓘ
2
Labelers (makers, repackagers, distributors)
3
Brand names ⓘ
24
FDA-listed product records ⓘ
2017
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (59) · Unfinished injection, solution (24) · Unfinished tablet (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Novo Nordisk Pharmaceutical Industries, LP83%
A-S Medication Solutions17%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Semaglutide Is Used (Medicaid Data)

How many Semaglutide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

5,813,664
Medicaid prescriptions filled (Q1–Q4 2025)
$6.53B paid by Medicaid, before rebates

How commonly is Semaglutide prescribed? Of the 1,682 medications we measure, Semaglutide ranks #31 by Medicaid prescriptions — more than 98% of them.

Where Semaglutide ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Semaglutide product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 0.25 mg / 0.5 mg / 3 mL / 0.68 mg/mL pen injector is the most-dispensed Semaglutide product — about 23% of these Medicaid prescriptions.

0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector Most dispensed

1,344,464 Medicaid prescriptions (Q1–Q4 2025) 23% of Semaglutide prescriptions shown $1.34B paid by Medicaid, before rebates ≈ $996 per prescription, before rebates

2 of 4 listed NDCs had Medicaid claims. RxNorm 2619152

3 ML semaglutide 2.68 MG/ML Pen Injector

1,208,802 Medicaid prescriptions (Q1–Q4 2025) 21% of Semaglutide prescriptions shown $1.25B paid by Medicaid, before rebates ≈ $1,031 per prescription, before rebates

1 of 5 listed NDCs had Medicaid claims. RxNorm 2599362

3 ML semaglutide 1.34 MG/ML Pen Injector

1,097,884 Medicaid prescriptions (Q1–Q4 2025) 19% of Semaglutide prescriptions shown $1.13B paid by Medicaid, before rebates ≈ $1,026 per prescription, before rebates

1 of 3 listed NDCs had Medicaid claims. RxNorm 2398841

0.75 ML semaglutide 3.2 MG/ML Auto-Injector

536,411 Medicaid prescriptions (Q1–Q4 2025) 9% of Semaglutide prescriptions shown $705.6M paid by Medicaid, before rebates ≈ $1,315 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 2554102

0.5 ML semaglutide 1 MG/ML Auto-Injector

371,289 Medicaid prescriptions (Q1–Q4 2025) 6% of Semaglutide prescriptions shown $481.2M paid by Medicaid, before rebates ≈ $1,296 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 2553601

0.5 ML semaglutide 0.5 MG/ML Auto-Injector

366,898 Medicaid prescriptions (Q1–Q4 2025) 6% of Semaglutide prescriptions shown $475.4M paid by Medicaid, before rebates ≈ $1,296 per prescription, before rebates

1 of 5 listed NDCs had Medicaid claims. RxNorm 2553501

0.5 ML semaglutide 2 MG/ML Auto-Injector

362,371 Medicaid prescriptions (Q1–Q4 2025) 6% of Semaglutide prescriptions shown $470M paid by Medicaid, before rebates ≈ $1,297 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 2553802

0.75 ML semaglutide 2.27 MG/ML Auto-Injector

327,855 Medicaid prescriptions (Q1–Q4 2025) 6% of Semaglutide prescriptions shown $428M paid by Medicaid, before rebates ≈ $1,306 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 2553901

semaglutide 14 MG Oral Tablet

79,126 Medicaid prescriptions (Q1–Q4 2025) 1% of Semaglutide prescriptions shown $105.6M paid by Medicaid, before rebates ≈ $1,334 per prescription, before rebates

1 of 4 listed NDCs had Medicaid claims. RxNorm 2200644

semaglutide 7 MG Oral Tablet

76,525 Medicaid prescriptions (Q1–Q4 2025) 1% of Semaglutide prescriptions shown $99.7M paid by Medicaid, before rebates ≈ $1,303 per prescription, before rebates

1 of 4 listed NDCs had Medicaid claims. RxNorm 2200656

semaglutide 3 MG Oral Tablet

41,995 Medicaid prescriptions (Q1–Q4 2025) <1% of Semaglutide prescriptions shown $48.6M paid by Medicaid, before rebates ≈ $1,158 per prescription, before rebates

1 of 7 listed NDCs had Medicaid claims. RxNorm 2200652

Other Semaglutide products: packs and listings not matched to one strength and form

44 Medicaid prescriptions (Q1–Q4 2025) <1% of Semaglutide prescriptions shown $35,061 paid by Medicaid, before rebates ≈ $797 per prescription, before rebates

1 of 339 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 13 of the 379 listed Semaglutide NDCs had Medicaid claims.

Compare Semaglutide Products

A representative set of FDA-listed product records for Semaglutide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 24 of 24 products — FDA National Drug Code Directory. See every product, package size and price: browse all 24 Semaglutide NDCs →

Semaglutide Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Semaglutide — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Semaglutide are nausea, vomiting, diarrhoea; about 50% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

78,023
Reports mentioning it
50%
Reported as serious
12
Distinct effects shown
Most reported effects
Nausea
11,150
Vomiting
7,332
Diarrhoea
6,833
Decreased Appetite
5,107
Constipation
4,976
Weight Decreased
4,777
Impaired Gastric Emptying
4,175
Blood Glucose Increased
3,460
Fatigue
3,252
Headache
3,240
Age groups
Adult · 12,046Elderly · 4,430Adolescent · 10Neonate · 9Child · 4Infant · 3

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Semaglutide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Semaglutide FDA Approval History

How Semaglutide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Semaglutide was first approved by the FDA in 2017 (Brand: OZEMPIC · Novo). It remains available in U.S. pharmacies today.

2017
Brand approved
Brand: OZEMPIC · Novo
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Semaglutide Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Semaglutide recalls since July 2021.

✅No Semaglutide recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Semaglutide in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
17
Forms in current FDA listings
3 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Semaglutide RxCUI 1991302
  1. Dose form (SCDF) Auto-Injector RxCUI 2553500
    In current FDA listings
    Its 6 strengths (SCD)
  2. Dose form (SCDF) Oral Tablet RxCUI 2200643
    In current FDA listings
    Its 7 strengths (SCD)
  3. Dose form (SCDF) Pen Injector RxCUI 1991305
    In current FDA listings

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Semaglutide Supply and Shortage Status

Whether Semaglutide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.

Semaglutide is not in shortage right now; the FDA has 3 past shortage records for it.

✅No current shortage of Semaglutide on record

A company has told the FDA it is discontinuing one version of Semaglutide. See which products it covers →

To be discontinued Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)
Novo Nordisk, Inc. · Since 06/04/2026 · Updated 06/04/2026
To be discontinued Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)
Novo Nordisk, Inc. · Since 06/04/2026 · Updated 06/04/2026
To be discontinued Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)
Novo Nordisk, Inc. · Since 06/04/2026 · Updated 06/04/2026

Source: openFDA, from the FDA Drug Shortages database.

What Semaglutide Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Semaglutide: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.

Form
Version
Strength

For brand-name Ozempic, the 0.68 mg/mL injection, pharmacies paid an average of $332.04 per mL as of Nov 18, 2026, up 3% from $322.38 a year earlier.

What pharmacies pay now
$332.04
per mL, as of Nov 18, 2026
Last 4 weeks
No change
from $332.02 on Oct 21, 2026
Last 12 months
Up 3%
from $322.38 on Nov 19, 2025
Lowest and highest since Nov 2023
$300.34 to $332.04
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Ozempic 0.68 mg/mL injection: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$332.04
Oct 2026$332.02
Sep 2026$331.99
Aug 2026$331.97
Jul 2026$331.97
Jun 2026$331.98
May 2026$332.00
Apr 2026$332.02
Mar 2026$332.02
Feb 2026$332.02
Jan 2026$332.02
Dec 2025$322.35
Nov 2025$322.38
Oct 2025$322.33
Sep 2025$322.31
Aug 2025$322.29
Jul 2025$322.25
Jun 2025$322.19
May 2025$322.21
Apr 2025$321.22
Mar 2025$321.22
Feb 2025$321.22
Jan 2025$321.22
Dec 2024$311.86
Nov 2024$311.81
Oct 2024$311.82
Sep 2024$311.81
Aug 2024$311.81
Jul 2024$311.81
Jun 2024$311.77
May 2024$311.83
Apr 2024$310.85
Mar 2024$310.85
Feb 2024$310.85
Jan 2024$310.85
Dec 2023$300.34
Nov 2023$300.34
See all 16 prices in a table
FormStrengthVersion What pharmacies pay
Injection · Subcutaneous 0.25 mg/0.5 mL Wegovy (brand) $653.33 per mL NDC details & price history
Injection · Subcutaneous 0.5 mg/0.5 mL Wegovy (brand) $653.05 per mL NDC details & price history
Injection · Subcutaneous 0.68 mg/mL Ozempic (brand) $332.04 per mL NDC details & price history
Injection · Subcutaneous 1 mg/0.5 mL Wegovy (brand) $653.08 per mL NDC details & price history
Injection · Subcutaneous 1.34 mg/mL Ozempic (brand) $332.00 per mL NDC details & price history
Injection · Subcutaneous 1.7 mg/0.75 mL Wegovy (brand) $435.40 per mL NDC details & price history
Injection · Subcutaneous 2.4 mg/0.75 mL Wegovy (brand) $435.31 per mL NDC details & price history
Injection · Subcutaneous 2.68 mg/mL Ozempic (brand) $332.05 per mL NDC details & price history
Injection · Subcutaneous 7.2 mg/0.75 mL Wegovy (brand) $435.06 per mL NDC details & price history
Tablet · Oral 1.5 mg Ozempic (brand) $33.16 per tablet NDC details & price history
Tablet · Oral 3 mg Rybelsus (brand) $33.19 per tablet NDC details & price history
Tablet · Oral 4 mg Ozempic (brand) $33.19 per tablet NDC details & price history
Tablet · Oral 7 mg Rybelsus (brand) $33.19 per tablet NDC details & price history
Tablet · Oral 9 mg Ozempic (brand) $33.19 per tablet NDC details & price history
Tablet · Oral 14 mg Rybelsus (brand) $33.19 per tablet NDC details & price history
Tablet · Oral 25 mg Wegovy (brand) $43.47 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Semaglutide Brand Names

Semaglutide has 3 brand names on record: Rybelsus, Ozempic and Wegovy. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Rybelsus 2019 Ozempic the first brand, 2017 Wegovy 2021

Who Makes Semaglutide: Manufacturers and Labelers

2 companies list Semaglutide products with the FDA. By number of product records, the largest are Novo Nordisk Pharmaceutical Industries, LP, A-S Medication Solutions. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Novo Nordisk Pharmaceutical Industries, LP 20 A-S Medication Solutions 4

Sources for This Semaglutide Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jun 18, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Semaglutide.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 6 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
6
Finished products in the current FDA directory
24
Companies listing them (makers, repackagers, distributors)
2
FDA labeler codes behind them ⓘ
2
Linked representative label ⓘ
Novo Nordisk
Linked label effective
Jun 18, 2026
Composite sections available
24
Linked SPL Set ID
ee06186f-2aa3-4990-a760-757579d8f77b
Linked SPL Document ID
f38985f6-b16a-426b-9c0d-6d4815acebfe
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Novo Nordisk is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →